RAGE inhibitor TTP488 (Azeliragon) suppresses metastasis in triple-negative breast cancer
Melinda Magna(University of Miami), Barry I. Hudson(Columbia University Irving Medical Center)
Cited by 37
Related Papers
Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE–/– mice
|Journal of Clinical Investigation|2008|363
Glucose, Glycation, and RAGE
|Journal of the American Society of Nephrology|2003|238
Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders
|Archives of Biochemistry and Biophysics|2003|165